Thoracic (Lung/chest)

NRG – LU008 at https://www.clinicaltrials.gov/study/NCT05624996?term=nct05624996&rank=1#locations

NCT05624996

Phase III Prospective Randomized Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed by Concurrent Mediastinal Chemoradiation for Locally-Advanced Non-Small Cell Lung Cancer

Cancer Type: Non-operable Stage IIB or III, node positive, (AJCC Eighth Edition) non-small cell lung cancer (NSCLC) with known PD-L1 status

Principal Investigator: Dr. Nathan Tennyson

Please contact Clinical Trials Office for more details: 561-263-5791

AZ TRITON – D419NL00003 at http://clinicaltrials.gov/study/NCT06008093

A Phase IIIb, Randomized, Multicenter, Open-Label Study to assess the Efficacy of Durvalumab plus Tremelimumab verus Chemotherapy for First-Line Treatment in Metastatic Non-Small Lung Cancer Patients with Non-Squamous Histology who have Mutations and/or Co-mutations in STK11, KEAP1 or KRAS

Cancer Type: NSCLC, Stage IV, Non-Squamous and Squamous

Principal Investigator: Dr. Ryan Devine

Please contact Clinical Trials Office for more details: 561-263-5791